Gossamer Bio, Inc.
GOSS
$0.16
-$0.02-11.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.74% | -252.07% | -201.39% | -117.96% | -71.60% |
| Total Depreciation and Amortization | -65.87% | -74.57% | -75.86% | -54.68% | -33.01% |
| Total Amortization of Deferred Charges | 495.93% | -3.38% | -9.30% | -15.92% | -23.05% |
| Total Other Non-Cash Items | -961.26% | 231.67% | 28.51% | -43.64% | -83.05% |
| Change in Net Operating Assets | 45.13% | -116.56% | -134.54% | -134.41% | -145.70% |
| Cash from Operations | -5.40% | -1,968.97% | -4,838.47% | -11,128.42% | -3,884.99% |
| Capital Expenditure | 100.00% | -103.85% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.16% | 1,765.93% | 439.01% | 454.00% | 171.29% |
| Cash from Investing | 88.32% | 1,761.33% | 438.74% | 453.79% | 171.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 621.16% | 719.49% | 921.46% | 292.69% | -99.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Financing | 263.48% | 176.32% | 155.93% | 117.16% | -99.52% |
| Foreign Exchange rate Adjustments | -201.98% | -200.00% | 238.24% | -93.52% | 1,653.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.50% | 222.00% | -159.74% | 63.93% | -221.44% |